Back to Search Start Over

Intravitreal Bevacizumab for Treatment of Bilateral Candida Chorioretinitis Complicated with Choroidal Neovascularization.

Authors :
Zonnevylle KE
Stanescu-Segall D
Source :
Ocular immunology and inflammation [Ocul Immunol Inflamm] 2020; Vol. 28 (1), pp. 39-42. Date of Electronic Publication: 2019 Aug 15.
Publication Year :
2020

Abstract

Purpose : The purpose of this report is to describe a case of bilateral Candida chorioretinitis complicated with choroidal neovascularization (CNV) and effectively treated with combined intravitreal bevacizumab and amphotericin B. Results : An 83-year-old patient was diagnosed with Candida chorioretinitis in both eyes. Optical coherence tomography and fluorescein angiography revealed CNV. Treatment using combined intravitreal bevacizumab and amphotericin B was initiated followed by a 4-weekly regimen of bevacizumab, eventually resulting in the regression of the subretinal fluid and intraretinal edema. Conclusion : Our study supports the combined use of intravitreal bevacizumab and amphotericin B in the management of CNV in Candida chorioretinitis.

Details

Language :
English
ISSN :
1744-5078
Volume :
28
Issue :
1
Database :
MEDLINE
Journal :
Ocular immunology and inflammation
Publication Type :
Report
Accession number :
31415218
Full Text :
https://doi.org/10.1080/09273948.2019.1623268